Tags:Artificial IntelligenceBioTechDataDesignHealthTechIndustryInformationITLearnPlanning
20n Bio is a VC-backed start-up dedicated to the computational design of novel protein therapeutics. Launched in 2021 and located in Malvern PA, its mission is addressing unmet medical needs by leveraging artificial intelligence to generate protein drugs in silico with desired biophysical, functional, and pharmacological properties.
Location: United States, California, San Francisco
Member count: 11-50
Founded date: 2021

Investors 1

DateNameWebsite
21.07.2020Y Combinat...ycombinato...

Mentions in press and media 6

DateTitleDescriptionCategoryAuthorSource
06.05.2015Все старта...Редакция ЦП собрала в одном ма...Трибуна...Дарья Хохл...vc.ru/trib...
25.03.2015The Top 10...Y Combinator unveiled one of i...20n, akido...Josh Const...techcrunch...
24.03.201547 Startup...Y Combinator got so big, it ha...akido labs...Josh Const...techcrunch...
26.02.201520n, A YC ...20n, one of a wave of biotech-...20n, Y Com...Kim-Mai Cu...techcrunch...
26.02.201520n (YC W1...“20n, one of a wave of biotech...YC News-blog.ycomb...
-YC and Har...Some people think YC only fund...--blog.ycomb...